Intellectual Property India Publishes Patent Application for 'Uridine Triacetate Amorphous Formulation And Uses Thereof' Filed by Pharma Cinq, Llc

MUMBAI, India, April 25 -- Intellectual Property India has published a patent application (202517010588 A) filed by Pharma Cinq, Llc, Rockville, U.S.A., on Feb. 7, for 'uridine triacetate amorphous formulation and uses thereof.'

Inventor(s) include Bamat, Michael, Kevin; Gao, Yi; Miller, Jeffrey, A.; Qiu, Yihong; and Von Borstel, Reid, W.

The application for the patent was published on April 25, under issue no. 17/2025.

According to the abstract released by the Intellectual Property India: "There is disclosed a dispersion of amorphous uridine triacetate in Hypromellose Acetate Succinate-MG and optionally also Copovidone. The amorphous dispersion compositions allow high loading of uridine. They also have good stability and oral bioavailab...